vs

Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and Kosmos Energy Ltd. (KOS). Click either name above to swap in a different company.

Kosmos Energy Ltd. is the larger business by last-quarter revenue ($294.6M vs $205.4M, roughly 1.4× COLLEGIUM PHARMACEUTICAL, INC). On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs -25.9%). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs -16.5%).

Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.

Kosmos Energy is an American upstream oil company founded and based in Dallas, Texas. While previously incorporated in Bermuda, Kosmos has reincorporated in Delaware. The company holds production and development operations offshore Ghana, Equatorial Guinea, and Gulf of Mexico, while holding a development project offshore Mauritania and Senegal, and exploration licenses offshore Namibia, São Tomé and Príncipe and Suriname. It was previously involved in exploration offshore Morocco and Western ...

COLL vs KOS — Head-to-Head

Bigger by revenue
KOS
KOS
1.4× larger
KOS
$294.6M
$205.4M
COLL
Growing faster (revenue YoY)
COLL
COLL
+38.8% gap
COLL
12.9%
-25.9%
KOS
Faster 2-yr revenue CAGR
COLL
COLL
Annualised
COLL
19.1%
-16.5%
KOS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
COLL
COLL
KOS
KOS
Revenue
$205.4M
$294.6M
Net Profit
$17.0M
Gross Margin
62.5%
Operating Margin
29.6%
-125.7%
Net Margin
8.3%
Revenue YoY
12.9%
-25.9%
Net Profit YoY
35.3%
EPS (diluted)
$0.48
$-0.80

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
COLL
COLL
KOS
KOS
Q4 25
$205.4M
$294.6M
Q3 25
$209.4M
$311.0M
Q2 25
$188.0M
$392.6M
Q1 25
$177.8M
$290.1M
Q4 24
$181.9M
$397.6M
Q3 24
$159.3M
$407.8M
Q2 24
$145.3M
$447.8M
Q1 24
$144.9M
$422.3M
Net Profit
COLL
COLL
KOS
KOS
Q4 25
$17.0M
Q3 25
$31.5M
$-124.3M
Q2 25
$12.0M
$-87.7M
Q1 25
$2.4M
$-110.6M
Q4 24
$12.5M
Q3 24
$9.3M
$45.0M
Q2 24
$19.6M
$59.8M
Q1 24
$27.7M
$91.7M
Gross Margin
COLL
COLL
KOS
KOS
Q4 25
62.5%
Q3 25
61.7%
Q2 25
57.7%
Q1 25
54.8%
Q4 24
54.0%
Q3 24
60.8%
Q2 24
62.5%
Q1 24
63.1%
Operating Margin
COLL
COLL
KOS
KOS
Q4 25
29.6%
-125.7%
Q3 25
29.7%
-34.2%
Q2 25
18.7%
-16.2%
Q1 25
12.2%
-32.4%
Q4 24
20.9%
-8.5%
Q3 24
21.9%
26.1%
Q2 24
32.7%
30.2%
Q1 24
34.1%
33.6%
Net Margin
COLL
COLL
KOS
KOS
Q4 25
8.3%
Q3 25
15.0%
-40.0%
Q2 25
6.4%
-22.3%
Q1 25
1.4%
-38.1%
Q4 24
6.9%
Q3 24
5.9%
11.0%
Q2 24
13.5%
13.3%
Q1 24
19.1%
21.7%
EPS (diluted)
COLL
COLL
KOS
KOS
Q4 25
$0.48
$-0.80
Q3 25
$0.84
$-0.26
Q2 25
$0.34
$-0.18
Q1 25
$0.07
$-0.23
Q4 24
$0.36
$0.00
Q3 24
$0.27
$0.09
Q2 24
$0.52
$0.12
Q1 24
$0.71
$0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
COLL
COLL
KOS
KOS
Cash + ST InvestmentsLiquidity on hand
$386.7M
$91.5M
Total DebtLower is stronger
$3.1B
Stockholders' EquityBook value
$301.7M
$528.6M
Total Assets
$1.7B
$4.7B
Debt / EquityLower = less leverage
5.78×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
COLL
COLL
KOS
KOS
Q4 25
$386.7M
$91.5M
Q3 25
$285.9M
$64.0M
Q2 25
$222.2M
$51.7M
Q1 25
$197.8M
$49.8M
Q4 24
$162.8M
$85.0M
Q3 24
$120.0M
$51.6M
Q2 24
$271.6M
$173.8M
Q1 24
$318.0M
$254.3M
Total Debt
COLL
COLL
KOS
KOS
Q4 25
$3.1B
Q3 25
$3.0B
Q2 25
$2.9B
Q1 25
Q4 24
$2.7B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
COLL
COLL
KOS
KOS
Q4 25
$301.7M
$528.6M
Q3 25
$274.8M
$898.8M
Q2 25
$232.2M
$1.0B
Q1 25
$234.4M
$1.1B
Q4 24
$228.8M
$1.2B
Q3 24
$234.3M
$1.2B
Q2 24
$216.6M
$1.1B
Q1 24
$222.2M
$1.1B
Total Assets
COLL
COLL
KOS
KOS
Q4 25
$1.7B
$4.7B
Q3 25
$1.6B
$5.1B
Q2 25
$1.6B
$5.2B
Q1 25
$1.6B
$5.3B
Q4 24
$1.7B
$5.3B
Q3 24
$1.6B
$5.5B
Q2 24
$1.1B
$5.4B
Q1 24
$1.1B
$5.4B
Debt / Equity
COLL
COLL
KOS
KOS
Q4 25
5.78×
Q3 25
3.31×
Q2 25
2.80×
Q1 25
Q4 24
2.29×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
COLL
COLL
KOS
KOS
Operating Cash FlowLast quarter
$123.0M
$35.3M
Free Cash FlowOCF − Capex
$122.4M
FCF MarginFCF / Revenue
59.6%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
7.25×
TTM Free Cash FlowTrailing 4 quarters
$327.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
COLL
COLL
KOS
KOS
Q4 25
$123.0M
$35.3M
Q3 25
$78.4M
$-27.6M
Q2 25
$72.4M
$127.2M
Q1 25
$55.4M
$-888.0K
Q4 24
$84.6M
$175.7M
Q3 24
$-9.0M
$6.3M
Q2 24
$67.4M
$223.7M
Q1 24
$61.9M
$272.6M
Free Cash Flow
COLL
COLL
KOS
KOS
Q4 25
$122.4M
Q3 25
$78.3M
Q2 25
$72.4M
Q1 25
$54.6M
Q4 24
$84.1M
Q3 24
$-9.2M
Q2 24
$67.1M
Q1 24
$61.4M
FCF Margin
COLL
COLL
KOS
KOS
Q4 25
59.6%
Q3 25
37.4%
Q2 25
38.5%
Q1 25
30.7%
Q4 24
46.2%
Q3 24
-5.8%
Q2 24
46.2%
Q1 24
42.3%
Capex Intensity
COLL
COLL
KOS
KOS
Q4 25
0.3%
Q3 25
0.1%
Q2 25
0.0%
Q1 25
0.4%
Q4 24
0.3%
Q3 24
0.2%
Q2 24
0.2%
Q1 24
0.4%
Cash Conversion
COLL
COLL
KOS
KOS
Q4 25
7.25×
Q3 25
2.49×
Q2 25
6.05×
Q1 25
22.92×
Q4 24
6.75×
Q3 24
-0.96×
0.14×
Q2 24
3.44×
3.74×
Q1 24
2.23×
2.97×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

COLL
COLL

Segment breakdown not available.

KOS
KOS

Ghana Segment$134.6M46%
Gulf Of America$80.7M27%
Mauritania And Senegal$54.9M19%
Equatorial Guinea Segment$24.3M8%

Related Comparisons